I wonder if anyone have update on Sequel performance and how it compares to RSII.
Unconfigured Ad
Collapse
X
-
There was a PacBio user group meeting in Baltimore (in last two weeks) where an update was given about Sequel performance (based on a note I saw from a FAS). Apparently that information has not been published but if someone on SeqAnswers was in attendance then they may be able to comment.
Comment
-
-
We don't have any data, but we have a (growing) list of service providers who have installed the Sequel platform: http://ngs.is/PBSequelOriginally posted by nucacidhunter View PostThanks GenoMax. The system release was announced almost 8 months ago and I thought there might be some installed machines in production or in validation phase where some operators might have been trained and seen some real data to compare with Sequel announced specs or RSII.
Comment
-
-
This is a big mystery. There are reports of machines in the wild (at least with close collaborators of PacBio) but no one seems to have released real data as yet. There is nothing EBI-ENA at this time either.Originally posted by nucacidhunter View PostThanks GenoMax. The system release was announced almost 8 months ago and I thought there might be some installed machines in production or in validation phase where some operators might have been trained and seen some real data to compare with Sequel announced specs or RSII.
Comment
-
-
A few service providers had told me they expect to start providing Sequel services in June. I expect we should see some data soon?
At the UGM pacbio did mention they expect to start shipping their new chip at the end of the month along with a new loading protocol. So maybe service providers are waiting for that? I'm sure Sequel owners here would have a better idea of whats going on though.
Comment
-
-
Hi Brian,
is this with your previous or the new employer?
Thanks!
A Sequel talk from April: https://www.youtube.com/watch?v=hmx3HGs9imsOriginally posted by Brian Bushnell View PostWe have two of them, but they are still being qualified.Last edited by luc; 06-20-2016, 09:46 AM.
Comment
-
-
-
It is hard to tell but the description for this dataset seems to include verbiage about Sequel (not sure why the submitters would include that if this was a RSII): http://www.ebi.ac.uk/ena/data/view/SRX1684788
Most likely a red herring but who knows. Raw bax/bas.h5 files are available in case someone is curious (http://trace.ncbi.nlm.nih.gov/Traces...run=SRR3342814 under Download tab).Last edited by GenoMax; 07-22-2016, 05:21 AM.
Comment
-
-
HiOriginally posted by Brian Bushnell View PostNo... most of what we sequence comes from remote users. But, we do all the library construction here, and I believe we reject samples that do not have high molecular weight DNA, or insufficient mass.
We are facing some issues with our new sequal system installed recently. Pacbio team is unable suggest loading clear loading concentration of different sized library.
The out put varies with each run and the maximum we got till now is 3.2gb for 2 kb library.
For the higher sized library the runs will yield 0.2-0.9gb per SMRT.We are unable to find out where the problem lies.Also after completing each run the volume of libraries pickedup from the sample well is not consistent.
Pac bio suggestion for the loading conc is 50-60pM for any size library.
There is another suggestion from PacBio is that system and smrtlink need to be restarted every 24 days, Is it true?
Please help
Comment
-
Latest Articles
Collapse
-
by mylaserKheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
This guide explains everything you need to know about...-
Channel: Articles
Today, 01:13 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
16 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
10 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|
||
|
Started by SEQadmin2, 07-07-2026, 11:05 AM
|
0 responses
22 views
0 reactions
|
Last Post
by SEQadmin2
07-07-2026, 11:05 AM
|
||
|
Started by SEQadmin2, 07-02-2026, 11:08 AM
|
0 responses
31 views
0 reactions
|
Last Post
by SEQadmin2
07-02-2026, 11:08 AM
|


Comment